British Journal of Clinical Pharmacology

Estimating impossible curves using NONMEM
pp. 283-290(8)
Authors: SCHOEMAKER, RIK C.; COHEN, ADAM F.

Clinical pharmacology of β₃-adrenoceptors
pp. 291-300(10)
Author: LIPWORTH, BRIAN J.

The effect of age on the pharmacokinetics of the opioid antagonist nalmefene
pp. 301-306(6)
Authors: FRYE, R. F.; MATZKE, G. R.; JALLAD, N. S.; WILHELM, J. A.; BIKHAZI, G. B.

A randomized, double-blind, placebo-controlled trial comparing pethidine to metamizol for treatment of post-anaesthetic shivering
pp. 307-311(5)
Authors: MONSÓ, A.; RIUDEUBAS, J.; BARBAL, F.; LAPORTE, J-R.; ARNAU, J. M.

Taste loss to terbinafine: a case-control study of potential risk factors
pp. 313-318(6)
Authors: STRICKER, B. H. Ch.; VAN RIEMSDIJK, M. M.; STURKENBOOM, M. C. J. M.; OTTERVANGER, J. P.

A prospective study of adverse drug reactions as a cause of admission to a paediatric hospital
pp. 319-324(6)
Authors: MARTÍNEZ-MIR, I.; GARCÍA-LÓPEZ, M.; PALOP, V.; FERRER, J. M.; ESTAÑ, L.; RUBIO, E.; MORALES-OLIVAS, F. J.

Single-dose pharmacokinetics of ampicillin and tobramycin administered by hypodermoclysis in young and older healthy volunteers
pp. 325-331(7)
Authors: CHAMPOUX, N.; DU SOUICH, P.; RAVAOARINORO, M.; PHANEUF, D.; LATOUR, J.; CUSSON, J. R.

Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio
pp. 333-337(5)
Authors: DE PINIEUX, G.; CHARIOT, P.; AMMI-SAÏD, M.; LOUARN, F.; LEJONC, J. L.; ASTIER, A.; JACOTOT, B.; GHERARDI, R.

Racial differences in propranolol enantiomer kinetics following simultaneous i.v. and oral administration
pp. 339-346(8)
Authors: SOWINSKI, KEVIN M.; LIMA, JOHN J.; BURLEW, BRAD S.; MASSIE, JAMES D.; JOHNSON, JULIE A.

The effect of fluconazole and ketoconazole on the metabolism of sulphamethoxazole
pp. 347-353(7)
Authors: GILL, HELEN J.; MAGGS, JAMES L.; MADDEN, STEPHEN; PIRMOHAMED, MUNIR; PARK, B. KEVIN

Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in athletes. Blood sampling and doping control
pp. 355-364(10)
Authors: SOUILLARD, AGNES; AUDRAN, MICHEL; BRESSOLLE, FRANÇOISE; GAREAU, RAYNALD; DUVALLET, ALAIN; CHANAL, JEAN-LOUIS

γ-l-glutamyl-5-hydroxy-l-tryptophan, but not γ-l-glutamyl-l-tryptophan, causes sodium retention in normal man
pp. 365-370(6)
Authors: LI KAM WA, T. C.; FREESTONE, S.; SAMSON, R. R.; JOHNSON, N. R.; LEE, M. R.

Suppression of vagus-mediated pancreatic polypeptide release by the μ-opiate receptor agonist loperamide in man
pp. 371-377(7)
Authors: RIEPL, RUDOLF L.; REICHARDT, BÄRBEL; AUERNHAMMER, CHRISTOPH J.; BEIER, GERALD; SCHOPOHL, JOCHEN; STALLA, GÜNTER K.; LEHNERT, PETER

Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-d-arginine vasopressin in adult patients with central diabetes insipidus
pp. 379-385(7)
Authors: LAM, K. S. L.; WAT, M. S.; CHOI, K. L.; IP, T. P.; PANG, R. W. C.; KUMANA, C. R.

Expression of CYP3A4, CYP3A5 and CYP3A7 in human duodenal tissue
pp. 387-389(3)
Authors: KIVISTÖ, KARI T.; BOOKJANS, GERHARD; FROMM, MARTIN F.; GRIESE, ERNST-ULRICH; MÜNZEL, PETER; KROEMER, HEYO K.

Variable contribution of CYP2D6 to the N-Dealkylation of S-(-)-propranolol by human liver microsomes
pp. 390-393(4)
Authors: ROWLAND, K.; WYNNE ELLIS, S.; LENNARD, M. S.; TUCKER, G. T.

Influence of liver cirrhosis on sertraline pharmacokinetics
pp. 394-397(4)
Authors: DÉMOLIS, JEAN-LOUIS; ANGEBAUD, PASCAL; GRANGÉ, JEAN-DIDIER; COATES, PETER; FUNCK-BRENTANO, CHRISTIAN; JAILLON, PATRICE